The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in red cells and plays a role in protection against oxidative damage

被引:23
|
作者
Xu, Xiuling [1 ]
Martin, Florent [1 ]
Friedman, Jeffrey S. [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
DJ-1; SOD2; Erythroblast; Oxidative stress; Parkinson's disease; CYSTEINE-SULFINIC ACID; SIDEROBLASTIC ANEMIA; SUPEROXIDE-DISMUTASE; PROTEIN DJ-1; STRESS; ANTIOXIDANT; ERYTHROCYTES; MUTATIONS; MICE;
D O I
10.1016/j.bcmd.2010.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antioxidant enzyme manganese superoxide dismutase (SOD2) serves as the primary defense against mitochondrial superoxide. Impaired SOD2 activity in murine hematopoietic cells affects erythroid development, resulting in anemia characterized by intra-mitochondrial iron deposition, reticulocytosis and shortened red cell life span. Gene expression profiling of normal and SOD2 deficient erythroblasts identified the Parkinson's disease locus DJ-1 (Park7) as a differentially expressed transcript. To investigate the role of DJ-1 in hematopoietic cell development and protection against oxidative stress caused by Sod2 loss, we evaluated red cell parameters, reticulocyte count, red cell turnover and reactive oxygen species production in DJ-1 knockout animals and chimeric animals lacking both SOD2 and DJ-1 in hematopoietic cells generated by fetal liver transplantation. We also investigated DJ-1 protein expression in primary murine erythroid and erythroleukemia cells (MEL). Loss of DJ-1 exacerbates the phenotype of SOD2 deficiency, increasing reticulocyte count and decreasing red cell survival. Using MEL cells, we show that DJ-1 is up-regulated at the protein level during erythroid differentiation. These results indicate that DJ-1 plays a physiologic role in protection of erythroid cells from oxidant damage, a function unmasked in the context of oxidative stress. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 37 条
  • [1] Protection Against Dopaminergic Neurodegeneration in Parkinson's Disease-Model Animals by a Modulator of the Oxidized Form of DJ-1, a Wild-type of Familial Parkinson's Disease-Linked PARK7
    Inden, Masatoshi
    Kitamura, Yoshihisa
    Takahashi, Kazunori
    Takata, Kazuyuki
    Ito, Natsuko
    Niwa, Rina
    Funayama, Risa
    Nishimura, Kaneyasu
    Taniguchi, Takashi
    Honda, Toshio
    Taira, Takahiro
    Ariga, Hiroyoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 117 (03) : 189 - 203
  • [2] The Parkinson's disease DJ-1/PARK7 gene controls peripheral neuronal excitability and painful neuropathy
    Lee, Sang Hoon
    Tonello, Raquel
    Lee, Kihwan
    Roh, Jueun
    Prudente, Arthur Silveira
    Kim, Yong Ho
    Park, Chul-Kyu
    Berta, Temugin
    BRAIN, 2025,
  • [3] PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target
    Lind-Holm Mogensen, Frida
    Scafidi, Andrea
    Poli, Aurelie
    Michelucci, Alessandro
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [4] Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
    Billia, Filio
    Hauck, Ludger
    Grothe, Daniela
    Konecny, Filip
    Rao, Vivek
    Kim, Raymond H.
    Mak, Tak W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (15) : 6085 - 6090
  • [5] PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model
    Inden, Masatoshi
    Taira, Takahiro
    Kitamura, Yoshihisa
    Yanagida, Takashi
    Tsuchiya, Daiju
    Takata, Kazuyuki
    Yanagisawa, Daijiro
    Nishimura, Kaneyasu
    Taniguchi, Takashi
    Kiso, Yoshiaki
    Yoshimoto, Kanji
    Agatsuma, Tomohiro
    Koide-Yoshida, Shizuyo
    Iguchi-Ariga, Sanae M. M.
    Shimohama, Shun
    Ariga, Hiroyoshi
    NEUROBIOLOGY OF DISEASE, 2006, 24 (01) : 144 - 158
  • [6] Protection Against Oxidative Stress-Induced Neurodegeneration by a Modulator for DJ-1, the Wild-Type of Familial Parkinson's Disease-Linked PARK7
    Yanagida, Takashi
    Kitamura, Yoshihisa
    Yamane, Koichiro
    Takahashi, Kazunori
    Takata, Kazuyuki
    Yanagisawa, Daijiro
    Yasui, Hiroyuki
    Taniguchi, Takashi
    Taira, Takahiro
    Honda, Toshio
    Ariga, Hiroyoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 (03) : 463 - 468
  • [7] Drug Repurposing for the Discovery of Potential Inhibitors Targeting DJ-1 (PARK7) Against Parkinson's Disease
    Aldakhil, Taibah
    Altharawi, Ali
    CRYSTALS, 2025, 15 (03)
  • [8] PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
    Frida Lind-Holm Mogensen
    Andrea Scafidi
    Aurélie Poli
    Alessandro Michelucci
    Journal of Neuroinflammation, 20
  • [9] The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
    Bandopadhyay, R
    Kingsbury, AE
    Cookson, MR
    Reid, AR
    Evans, IM
    Hope, AD
    Pittman, AM
    Lashley, T
    Canet-Aviles, R
    Miller, DW
    McLendon, C
    Strand, C
    Leonard, AJ
    Abou-Sleiman, PM
    Healy, DG
    Ariga, H
    Wood, NW
    de Silva, R
    Revesz, T
    Hardy, JA
    Lees, AJ
    BRAIN, 2004, 127 : 420 - 430
  • [10] Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease
    Skou, Line Duborg
    Johansen, Steffi Krudt
    Okarmus, Justyna
    Meyer, Morten
    CELLS, 2024, 13 (04)